pretickt

PFE peers and competitors

Pfizer Inc. · end-of-day data as of Oct 16, 2026

Pfizer Inc.
PFE · $169B
$29.58+20.5%last 60 sessions · close Oct 16, 2026
$22.64$29.5852 weeks
Hold · 28 analystsPT $27.49 -7.1%
  • P/E vs own+84.3%
  • P/E vs sector+38.8%
  • Target upside-7.1%
  • Off 52w high0.0%
  • Insiders$2.88M
  • FCF yield+6.5%
  • Earnings in18d
  • Trendbullish
  • Sector▲ +16.0%
  • RSI70
  • MA20×50—
  • Volume0.9x
  • Support-3.3%
  • Resistance—

PFE’s peers by industry and size include Eli Lilly (LLY), Johnson & Johnson (JNJ) and AbbVie (ABBV). Among these 12 companies PFE ranks 8th by market cap ($169B); its P/E of 39.1 compares with a median of 40.9 for its peers.

Peers by industry and size

20D
1LLYEli Lilly and Company$1,257.03+0.4%-1.8%+4.5%42.2$1.18T
2JNJJohnson & Johnson$255.56+0.9%-8.2%+8.8%38.7$616B
3ABBVAbbVie Inc.$285.42+0.7%0.0%-1.4%80.4$504B
4MRKMerck & Co., Inc.$145.95+0.5%-6.2%+7.7%116.8$360B
5AMGNAmgen Inc.$432.49-0.4%-2.6%-7.5%26.9$234B
6GILDGilead Sciences, Inc.$156.19-0.7%-0.7%+1.9%—$194B
7ABTAbbott Laboratories$104.89+0.2%-17.7%+16.6%33.7$181B
8PFEPfizer Inc.$29.58+0.5%0.0%-7.1%39.1$169B
9DHRDanaher Corporation$229.04-1.1%-4.8%+2.8%40.7$161B
10ISRGIntuitive Surgical, Inc.$426.70-0.3%-28.0%+12.1%48.5$151B
11BMYBristol-Myers Squibb Company$59.75-1.4%-11.3%+9.4%13.2$122B
12BIIBBiogen Inc.$232.65-1.1%-1.1%+2.7%41.2$34.37B

Data as of Oct 16, 2026 close.